MacLennan et al., "Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease," British Journal of Ophthalmology, vol.
Mirza, "The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study," Graefe's Archive for Clinical and Experimental Ophthalmology, vol.
Tsubota, "Autologous serum eye drops for the treatment of dry eye diseases," Cornea, vol.
Tsubota, "Autologous serum eye drops for dry eye after LASIK," Journal of Refractive Surgery, vol.
One prospective, randomized study found that TBUT and rose bengal staining were significantly improved after LASIK in patients who received
autologous serum eye drops, whereas no change in these parameters was reported in the patients who received only artificial tears [81].
Autologous serum eye drops diluted at 20%, eight times a day, and a taper of loteprednol 0.5% ophthalmic solution, one drop four times a day for two weeks, then two times a day for two weeks, were commenced in both eyes.
This report may suggest that treatment with autologous serum eye drops could result in faster resolution of signs and symptoms of UV-related keratopathy and regeneration of subbasal corneal nerves.
These findings are consistent with our outcomes using autologous serum eye drops in the present case report with UV keratitis.
